Leadership

“The industry cannot keep building the way it has and expect to be ready for what is coming.”

Dr. Jason Murphy has over 25 years in bioprocess engineering at Moderna, Eli Lilly, and Merck. At Moderna he was a pivotal figure in the development and manufacturing of the COVID-19 vaccine, leading a cross-functional team through rapid, high-stakes production, and went on to work on personalized cancer therapeutics.

At Eli Lilly he led the Lilly Fermentation Development Technical Center. His work extended across the Biotech and Fermented Products Network, supporting operations behind a substantial share of Elanco revenue.

During 14 years at Merck he was a key contributor to process development and commercialization of vaccines and biologics.

He holds a B.S. in Chemical Engineering from the University of California, Berkeley, and an M.S. and Ph.D. in Chemical Engineering from the University of Houston.

“Partnerships only matter when they turn into product. Our job is to align the two.”

Matt Krusen brings over a decade of commercial leadership in biomanufacturing, with deep expertise across gene and cell therapy platforms. Before Electron Bio he held senior roles at Aldevron, leading client development, GMP strategy, and strategic alliances supporting global programs in plasmid DNA, mRNA, and viral vector production.

He has worked at the intersection of science and business throughout his career, helping biopharma partners navigate manufacturing scale-up, regulatory requirements, and CMC planning.

At Electron Bio he leads business development and strategic partnerships, accelerating client programs across the company's advisory, infrastructure, and digital capabilities.

He holds an M.S. in Biochemistry and Integrated Biomedical Science, with a focus in Infectious Disease, from the University of Notre Dame.